Techne, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $297.03 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 4.11%.

Keybank National Association OH boosted its position in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 66.4% in the ...

Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific ...

TECHNE is a practice-based digital arts research initiative founded by Professor Mark Amerika, at the University of Colorado at Boulder. The TECHNE initiative develops innovative approaches to the ...

Bio-Techne (TECH) announced the launch of an expanded menu of human and mouse RNAscope in situ hybridization probes to advance spatial biology research and the development of next-generation ...

Mirae Asset Global Investments Co. Ltd. grew its stake in shares of Bio-Techne by 46.6% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 16,650 shares of the ...

MINNEAPOLIS, Feb. 18, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a leading provider of innovative life science research tools, is pleased to announce the official release of GMP ...

Citi lowered the firm’s price target on Bio-Techne (TECH) to $70 from $80 and keeps a Neutral rating on the shares. The firm updated models in the life science tools and diagnostics group post ...

In the last three months, 4 analysts have published ratings on Bio-Techne TECH, offering a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments, the table ...

Headquartered in Minneapolis, Minnesota, Bio-Techne Corporation (TECH) is a leading provider of life sciences solutions dedicated to advancing biomedical research and diagnostics. With a market ...

(RTTNews) - Bio-Techne Corp. (TECH) announced earnings for its second quarter that increased from last year and beat the Street estimates. The company's bottom line totaled $34.89 million ...